SB 273

  • Indiana Senate Bill
  • 2024 Regular Session
  • Introduced in Senate
  • Passed Senate Feb 06, 2024
  • Passed House Feb 27, 2024
  • Signed by Governor Mar 11, 2024

Biomarker testing coverage.

Abstract

Requires a health plan (which includes a policy of accident and sickness insurance, a health maintenance organization contract, the Medicaid risk based managed care program, and a state employee health plan) to provide coverage for biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's disease or condition when biomarker testing is supported by medical and scientific evidence. Requires the office of Medicaid policy and planning to provide biomarker testing as a Medicaid program service, and to apply to the United States Department of Health and Human Services for approval of any waiver necessary under the federal Medicaid program for the purpose of providing biomarker testing. Provides that coverage is not required for biomarker testing for screening purposes. Provides that if a prior authorization requirement applies to biomarker testing, the health plan or a third party acting on behalf of the health plan must: (1) approve or deny a request for prior authorization; and (2) notify the covered individual of the approval or denial; in not more than five business days in the case of a nonurgent request or in not more than 48 hours in the case of an urgent request. Requires the office of the secretary of family and social services to report certain information to the budget committee on Medicaid reimbursement rates provided for biomarker testing.

Bill Sponsors (14)

Votes


Actions


Mar 11, 2024

Office of the Governor

Signed by the Governor

Senate

Public Law 37

Mar 08, 2024

Senate

Signed by the President of the Senate

Mar 07, 2024

House

Signed by the Speaker

Mar 04, 2024

Senate

Signed by the President Pro Tempore

Feb 28, 2024

House

Returned to the Senate without amendments

Feb 27, 2024

House

Third reading: passed; Roll Call 236: yeas 94, nays 0

Feb 26, 2024

House

Second reading: ordered engrossed

Feb 22, 2024

House

Committee report: do pass, adopted

Feb 15, 2024

House

Representative Lehman added as cosponsor

House

Committee report: do pass, adopted

House

Referred to the Committee on Ways and Means pursuant to House Rule 127

Ways and Means

House

Representative Porter added as cosponsor

Feb 13, 2024

House

Representative Clere added as cosponsor

Feb 12, 2024

House

First reading: referred to Committee on Insurance

  • Reading-1
  • Referral-Committee
Insurance

Feb 07, 2024

Senate

Referred to the House

Feb 06, 2024

Senate

House sponsor: Representative Barrett

Senate

Third reading: passed; Roll Call 142: yeas 47, nays 1

Feb 05, 2024

Senate

Second reading: ordered engrossed

Feb 01, 2024

Senate

Senator Randolph added as coauthor

Senate

Senator Ford J.D. added as coauthor

Senate

Committee report: amend do pass, adopted

Senate

Senator Yoder added as coauthor

Jan 25, 2024

Senate

Senator Glick added as coauthor

Jan 23, 2024

Senate

Senator Bassler added as coauthor

Jan 22, 2024

Senate

Senator Bohacek added as coauthor

Jan 18, 2024

Senate

Senator Leising added as third author

Senate

Committee report: amend do pass adopted; reassigned to Committee on Appropriations

  • Committee-Passage
  • Referral-Committee
Appropriations

Jan 16, 2024

Senate

Senator Qaddoura added as coauthor

Jan 11, 2024

Senate

Authored by Senators Charbonneau and Becker

Senate

First reading: referred to Committee on Insurance and Financial Institutions

  • Reading-1
  • Referral-Committee
Insurance and Financial Institutions

Bill Text

Bill Text Versions Format
Enrolled Senate Bill (S) PDF
Senate Bill (S) PDF PDF
Senate Bill (H) PDF PDF
Introduced Senate Bill (S) PDF

Related Documents

Document Format
Fiscal Note: SB0273.06.ENRH.FN001 PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Indiana General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.